Details for Patent: 12,064,442
✉ Email this page to a colleague
Which drugs does patent 12,064,442 protect, and when does it expire?
Patent 12,064,442 protects RYALTRIS and is included in one NDA.
This patent has ninety patent family members in thirty-three countries.
Summary for Patent: 12,064,442
| Title: | Treatment of allergic rhinitis using a combination of mometasone and olopatadine |
| Abstract: | The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt. |
| Inventor(s): | Neelima Khairatkar-Joshi, Abhay Kulkarni, Dinesh Pradeep WALE, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. TANTRY, Chad OH |
| Assignee: | Glenmark Specialty SA |
| Application Number: | US17/807,487 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 12,064,442
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | RYALTRIS | mometasone furoate; olopatadine hydrochloride | SPRAY, METERED;NASAL | 211746-001 | Jan 13, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF SEASONAL ALLERGIC RHINITIS BY NASALY ADMINISTERING A COMBINATION OF OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,064,442
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3043773 | ⤷ Start Trial | CA 2021 00050 | Denmark | ⤷ Start Trial |
| European Patent Office | 3043773 | ⤷ Start Trial | 301154 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3043773 | ⤷ Start Trial | 122021000085 | Germany | ⤷ Start Trial |
| European Patent Office | 3043773 | ⤷ Start Trial | 132021000000191 | Italy | ⤷ Start Trial |
| European Patent Office | 3043773 | ⤷ Start Trial | 57/2021 | Austria | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
